JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (2006) 37 63-69    DOI: 10.1677/jme.1.02053
© 2006 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naik, K.
Right arrow Articles by Wondisford, F. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naik, K.
Right arrow Articles by Wondisford, F. E

A novel technique for temporally regulated cell type-specific Cre expression and recombination in the pituitary gonadotroph

Karuna Naik1, Isaiah Pittman, IV1, Andrew Wolfe2, Ryan S Miller3, Sally Radovick3 and Fredric E Wondisford3,4

1 Departments of Medicine,
2 Pediatrics, University of Chicago, Chicago, Illinois 60637, USA
3 Departments of Pediatrics,
4 Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA

(Requests for offprints should be addressed to F E Wondisford; Email: fwondisford{at}jhmi.edu)

Inducing tissue-specific genetic alterations under temporal control allows for the analysis of gene function in particular cell types at specified points in time. We have generated a system for tetracycline-controlled expression of Cre recombinase in mice using the unique CreTeR vector. The gonadotroph-specific bovine {alpha}-subunit (B{alpha}) promoter fragment was subcloned into the CreTeR vector, creating a technique for highly regulated expression of Cre recombinase exclusively in pituitary gonadotrophs. Control of Cre recombinase in the CreTeR vector was demonstrated in LßT2 pituitary cell lines, where Cre protein was detected in cells treated with doxycycline, but not in untreated cells. In transgenic mice, Cre was expressed in pituitary gonadotrophs of mice treated with doxycycline, but not in non-pituitary tissues or in transgenic mice not treated with doxycycline. We demonstrated Cre expression in the gonadotroph by immunostaining showing co-localization of Cre recombinase with the ß-subunit of LH (LH-ß). Furthermore, by crossing B{alpha}/CreTeR with R26R mice, we were able to demonstrate functional recombination within pituitary gonadotrophs, detected by lacZ expression. The B{alpha}/CreTeR mice described here can be used to study the function of virtually any gene in the gonadotroph; in particular, this will be useful in studying genes, which may have distinct roles in development and in the adult.




This article has been cited by other articles:


Home page
EndocrinologyHome page
U. B. Kaiser
Genetic Labeling: New Approaches to Creating a Gonadotroph "ID"
Endocrinology, June 1, 2008; 149(6): 2699 - 2700.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.